评价介入再通技术治疗配合术后中医治疗输卵管堵塞性不孕症的临床应用价值。

选取我院于1998年6月—2014年6月间收治的经过输卵管造影证实为输卵管间质部至壶腹部堵塞的患者10 000例，将其随机分为2组，观察组（介入再通术后配合中药治疗）5 000例，对照组（单纯介入治疗组）5 000例，分析全部患者介入治疗后的输卵管再通率，比较2组患者输卵管再通率和一年内的正常宫内受孕率。

本组治疗10 000例输卵管堵塞患者，介入再通治疗成功9 700例，再通率为97%，观察组的再通率为97.26%（4 863/5 000），与对照组的再通率96.74%（4 837/5 000）差异无统计学意义（χ²=2.323，P=0.127）；观察组5 000例中正常宫内受孕2 125例，受孕率为42.5%；对照组5 000例中正常宫内受孕950例，受孕率为19.0%，观察组高于对照组，差异有统计学意义（χ²=648.352，P<0.01）。

输卵管堵塞行介入再通治疗开通率高，安全性高，临床疗效显著，在介入再通术后配合中医治疗可以明显提高正常宫内受孕率。

To evaluate the clinical application value of a combined fallopian tube blockage treatment of interventional recanalization with post-surgery Chinese medication.

10 000 patients with fallopian tube blockages between the interstitial part to ampulla were treated in our hospital from June 1998 to June 2014. They were enrolled in this study and randomly divided into two groups - the treatment group (i.e., by interventional recanalization followed up by Chinese medical treatment) and the control group (i.e., by interventional recanalization only) , with 5 000 cases for each group. Recanalization rate after the fallopian tube interventional treatment was analyzed based on all selected patients. Fertility rate in the following year was then compared between the two groups.

With 9 700 successful interventional recanalization cases out of the 10 000 cases, the recanalization rate reached to 97%. Fertility rate was 42.5% (2 125/5 000) for the treatment group and 19% (950/5 000) for the control group, the former was much higher than the latter. The difference in the treatment result was statistically significant (χ²=648.352, P<0.01).

Interventional recanalization is a safe strategy for treating fallopian tube blockage. It has a high recanalization rate and significant clinical efficacy. Application of traditional Chinese medical treatment after recanalization can significantly improve intrauterine pregnancy rate.